Semaglutide is an injectable drug that is released once weekly and helps people with obesity manage weight loss
It has the promise of saving and improving many lives.As such, Skibicka said it was unlikely that the appearance of rare but serious side effects would be grounds to create new, stricter recommendations for prescribing GLP-drugs.Researchers are also finding surprising 'beneficial' side effects of taking GLP-1 dugs, too.Studies show that GLP-1 drug use is associated with a reduced risk of dementia and Alzheimer's disease
Available at: https://www.plasticsurgery.org/news/plastic-surgery-statistics
In line with BSSM guidance and testosterone SmPCs (e.g., Nebido), TRT should be paused or the dose reviewed if haematocrit exceeds 0.54
If you have any complaints or copyright issues related to this article, kindly contact the author above.
Increased use of GLP-1 receptor agonists, such as semaglutide (Ozempic, Wegovy), has greatly impacted treatment patterns